Clinical Trial

New Orleans Pulmonary Hypertension Biobank

Study acronym: NO-PH Biobank
Recruiting
View on ClinicalTrials.gov →
Summary
Pulmonary hypertension (PH) is a serious condition characterized by a mean pulmonary artery pressure \>=25mmHg on right heart catheterization (RHC). Despite advances in PH care, outcomes are still sub-optimal and further research is required into the pathobiology of the disease and development of biomarkers that can guide clinical care. The investigators are establishing a biobank to collect samples (blood, urine, stool) from patients with pulmonary hypertension, patients at high risk for pulmonary hypertension, healthy controls, and patients undergoing right heart catheterization. Specimens will be stored for future investigations.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2017-08-30; most recent amendment 2021-09-09.
Status change: Not Yet Recruiting → Recruiting 2018-01-11
Trial Details
NCT Number NCT03269630
Lead Sponsor Louisiana State University Health Sciences Center in New Orleans
Conditions Pulmonary Hypertension, Systemic Sclerosis, Mixed Connective Tissue Disease, Heart Failure With Normal Ejection Fraction, Healthy
Enrollment 450 participants
Start Date 2017-12-29
Primary Completion 2027-10 (estimated)
Study Completion 2027-10 (estimated)
Updated on ClinicalTrials.gov 2021-09-10